Smith & Nephew at CIIE: Empowering Local Healthcare Transformation and Enabling Life's Unlimited Potential

On November 5, 2023, the 6th China International Import Expo (hereinafter referred to as the “CIIE”) grandly opened at the National Exhibition and Convention Center in Shanghai. Smith & Nephew (LSE: SN; NYSE: SNN), a global leader in integrated medical technology, participated in the CIIE under the theme “Reshaping Renewal, Exploring Infinite Possibilities.” The company comprehensively showcased its cutting-edge healthcare solutions across four key areas and its innovation strategy, setting an industry benchmark and stimulating sustainable momentum for the sector.

Hu Hai, Managing Director of Smith & Nephew Greater China, stated, “Smith & Nephew has been deeply committed to the Chinese market since 1994, dedicated to providing advanced medical solutions to the local market and enhancing health experiences. The openness and inclusiveness of the Chinese market have also given Smith & Nephew full confidence in future cooperation. This year marks Smith & Nephew’s third consecutive participation in the China International Import Expo (CIIE). We hope to leverage this major platform for exchange and integration to showcase Smith & Nephew’s century-long heritage and innovative vitality, join hands with guests from all over the world to explore pathways for upgrading the health ecosystem, and contribute to the Healthy China 2030 initiative.”

2023 CIIE Smith & Nephew Booth

As one of the earliest global medical technology companies to enter China, Smith & Nephew has been deeply rooted in the Chinese market for nearly 30 years, witnessing the development of China’s healthcare sector. In recent years, as China’s healthcare reforms and innovations in medical security policies have accelerated, Smith & Nephew has remained committed to “bringing in” its globally leading healthcare solutions and innovative technologies. By engaging in extensive collaboration with numerous local industry partners, the company aims to build a broader ecosystem that leverages the combined strengths of all stakeholders. This strategy is designed to continuously enhance the depth and breadth of high-quality medical resources and services, ultimately benefiting more patients.

To better serve local customers and patients, Smith & Nephew has established manufacturing bases and after-sales service centers in China. This initiative not only optimizes the medical service experience but also integrates its Chinese production facilities into the global supply chain, actively promoting the dual circulation strategy that leverages both domestic and international markets.

At this year's China International Import Expo, Smith & Nephew unveiled three new products for the first time in the Chinese market, leading industry innovation with cutting-edge technologies. Among them,ENTACT Septal StaplerAs the first absorbable nail-based nasal septum fixator in China, the launch of this product ushers in an era of mechanical fixation with absorbable nails for septoplasty, transforming the method of tissue closure in nasal septum surgery. This innovation shortens operative time, minimizes damage to surrounding tissues, and helps surgeons achieve more uniform and stable surgical outcomes. AndPlasma Surgical Device WEREWOLFIt represents an upgrade to the COBLATION II plasma system, embodying Smith & Nephew’s continuous iteration and refinement of low-temperature plasma technology over more than two decades. This advancement significantly enhances surgical ablation efficiency and stability while strengthening intraoperative safety protections, thereby delivering a superior overall postoperative experience for both physicians and patients, along with safe and predictable therapeutic outcomes. It is indicated for the prevention of complications at surgical sites in high-risk populations and for the treatment of acute and chronic wounds.Single-Use Negative Pressure Wound Therapy System PICO 14, it leverages its unique operational model to deliver negative pressure wound therapy (NPWT) through the entire dressing to the wound or incision and the surrounding area, while simultaneously removing exudate, thereby providing patients with a more convenient and unrestricted experience.

 CIIE 2023: Smith & Nephew Unveils Three New Products Making Their China Debut

Furthermore, the Smith & Nephew booth was designed around its end-to-end service capabilities, comprehensively showcasing comprehensive solutions and innovative technologies across four key business segments: bone repair, sports injury repair, wound care, and ENT surgery. These offerings aim to drive intelligent and precise upgrades in each respective specialty area, includingFully Intelligent Integrated Orthopedic Robot System REAL INTELLIGENCE CORI, Tendon Repair Patch Kit REGENETENStar products, among others, made another appearance, drawing widespread attention from attendees and showcasing Smith & Nephew’s robust medical capabilities through its proprietary technologies.

Smith & Nephew's Star Products at the 2023 CIIE

As a British medical technology company with over 160 years of history, Smith & Nephew remains true to its original mission of “Enabling Possibilities for Life.” Grounded in its three cultural pillars—Care, Courage, and Collaboration—the company leverages forward-looking insights and continuous innovation to navigate rapid market changes, revitalize its operations, and pursue sustained growth. Today, recognizing the growing customer demand for more comprehensive and flexible products and solutions, Smith & Nephew is gradually transforming from a provider of standalone surgical medical products into a holistic perioperative (pre-operative, intra-operative, and post-operative) management solutions provider. By capitalizing on its extensive product portfolio and leading product innovation capabilities, the company is driving sustainable business development.

Smith & Nephew continues to explore its business model and has established an Integrated Business Solutions (IBS) division this year. By adopting a customer-centric approach and integrating corporate resources, the company provides comprehensive business solutions. Meanwhile, Smith & Nephew is actively expanding into retail channels and will officially launch the Smith & Nephew Retail E-commerce Ecosystem Alliance at this year’s China International Import Expo (CIIE). In collaboration with multiple partners, the initiative aims to explore new opportunities and enable direct access to advanced medical resources for patients.

Beyond its own growth, Smith & Nephew takes an industry-wide perspective, leveraging its deep expertise in medical technology to empower healthcare professionals and foster a healthy industry ecosystem. Since 2009, Smith & Nephew has provided various educational initiatives for healthcare professionals, including training programs, advanced study opportunities, and courses. These efforts have supported the professional development of tens of thousands of medical practitioners, delivering sustained momentum to advance both the healthcare industry and public health.

The Chinese market is one of Smith & Nephew’s most critical growth markets, both now and for the foreseeable future. Moving forward, Smith & Nephew will continue to deepen its commitment to China, providing healthcare professionals and patients with more comprehensive localized solutions. By leveraging innovative technologies, the company aims to help more users overcome life’s limitations, restore physical function and confidence, and collaborate with industry partners to realize “Limitless Possibilities for Life.”

For more information on Smith & Nephew products and solutions, please visit the Smith & Nephew booth at Stand C4-02, Hall 7.1, in the Medical Devices and Pharmaceuticals & Healthcare Exhibition Area. The booth features extensive interactive zones to help you learn more about scar management, with opportunities to participate in prize-winning quizzes and receive gifts that reflect the company’s century-long heritage.

Smith & Nephew, founded in Hull, UK in 1856, is a British diversified medical device company with a history spanning over 160 years. It is listed on both the London Stock Exchange (stock code: SN) and the New York Stock Exchange (stock code: SNN), and is a constituent of the FTSE 100 Index. Guided by its mission to enable limitless possibilities for life, Smith & Nephew now operates in more than 100 countries worldwide, employing nearly 20,000 people globally. Its products in orthopedic reconstruction, sports medicine, wound care, and ear, nose, and throat (ENT) surgery are renowned worldwide.

Smith & Nephew established its representative office in Shanghai in 1994 to conduct business in China, making it one of the first global medical technology companies to enter the Chinese market. Currently, Smith & Nephew has its Greater China headquarters in Shanghai and a manufacturing base in Suzhou, with products sold worldwide.